Finzati - Logo
PRE logo

Prenetics Global Limited

PRE • Medical - Diagnostics & Research
$18.63
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$321.67M
Growth
31.9%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive revenue growth · 18.0%Manageable debt level · 0.01Healthy liquidity · 3.01Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 20, 2026, 12:13 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$18.63
Change0.00%
Shares Out17.27M
Market Cap$321.67M
Enterprise Value$212.81M
52W Range7.17 - 23.63
Beta0.25
P/E-4.76
P/S2.26
P/B3.46
P/FCF-3.09
EV/Sales1.49

Investment DNA

How strong this company looks for long-term investors

58
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score▼
Positive revenue growth · 18.0%Manageable debt level · 0.01Healthy liquidity · 3.01Weak profitability

Analyst view

Analyst sentiment and price target

PRE
Analyst sentiment
Based on 2 analyst votes · 2026-10-20
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Price Target
2026-08-20
Low
$35.00
Mean
$35.00
Median
$35.00
High
$35.00

Company Overview

IPO: 7/16/2021
Industry: Medical - Diagnostics & Research
P/B i: 3.46
Debt / Equity i: 0.01
Operating Margin: -41.27%
Net Margin: -40.82%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 3.01
Quick Ratio: 2.76
Status: Good

Insider Transactions

Recent executive and insider activity

Tat Thuan Yen
Transaction: 08/03/2026
OTHER
Change
0
Price
Not reported
Filing
08/12/2026
Type
OTHER
Leogrande Hudson Blake
Transaction: 08/04/2026
BUY
Change
+2,001
Price
Not reported
Filing
08/05/2026
Type
BUY
Leogrande Hudson Blake
Transaction: 08/04/2026
SELL
Change
-2,001
Price
Not reported
Filing
08/05/2026
Type
SELL